Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 172
Selected: 0
NCT IDTitle
NCT00176488Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT00251186First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
NCT05400941Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
NCT00385398QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
NCT04713449Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
NCT02177838Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
NCT02748564Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
NCT00003365Sulindac and Plant Compounds in Preventing Colon Cancer
NCT00776594Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT03061175Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy
NCT02203604High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
NCT03257163Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
NCT00634634Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
NCT04075734Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors
NCT05785780Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT04871516Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
NCT00608972Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
NCT06704295High Impact E-cigarette Advertisement Features
NCT00786682Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
NCT01694589A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
NCT03102060Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
NCT00770419Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
NCT04179227Focus Group in Collecting Feedbacks From Indoor Tanning Bed Users for Social Media-Delivered Intervention Development
NCT01951534Decisional Aid Intervention for Women Considering Breast Reconstruction
NCT04920344Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT03677739Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT00118131Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00891969Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
NCT00176631Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT02144701Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
NCT07773415The Impact of Cigar Pack Marketing With "Natural" Themes on Young Adults
NCT02105116AML Therapy With Irradiated Allogeneic Cells
NCT03112668Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
NCT04972019Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
NCT02324621Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
NCT00176605Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
NCT02117817Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
NCT00822952Prostate Mechanical Imager (PMI) Clinical Bridging Study
NCT01510119Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
NCT00295932Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
NCT06927700Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
NCT02250781Oral ONC201 in Treating Patients With Advanced Solid Tumors
NCT00667901Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00895115Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
NCT05296421Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
NCT02420652Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
NCT00176644Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT04294264TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer